Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    19466965 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell Lymphoma
Condition: Anaplastic Large-Cell Lymphoma
Intervention: Drug: SGN-30 (anti-CD30 mAb)

Study has passed its completion date and status has not been verified in more than two years.